Capstone Investment Advisors
NUVB icon

Capstone Investment Advisors’s Nuvation Bio NUVB Stock Holding History

Capstone Investment Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-112,170
Closed -$481K – 1836
2026
Q1 		$481K Buy
112,170
+98,018
+693% +$546K ﹤0.01% 1151
2025
Q4 		$127K Buy
+14,152
New +$87.7K ﹤0.01% 1522
2021
Q2 		– Sell
-28,338
Closed -$296K – 1822
2021
Q1 		$296K Buy
+28,338
New +$317K ﹤0.01% 1364

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capstone Investment Advisors's NUVB Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 112,170 shares — an estimated $481K sold.

Capstone Investment Advisors first reported a position in NUVB in Q1 2021 and held it in 3 quarters. The position peaked at $481K in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 112,170 Nuvation Bio shares in Q2 2026, an estimated $481K.
  • Capstone Investment Advisors first reported a position in Nuvation Bio in Q1 2021 and held it in 3 quarters.
  • Capstone Investment Advisors's Nuvation Bio position peaked at $481K in Q1 2026.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.